Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinazolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed method for 2-trifluoromethyl quinazolinones offers high yields and broad substrate scope for efficient drug molecule synthesis.
Patent CN112480015B reveals a novel one-pot method for synthesizing 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction and scalability for API manufacturing.
Novel copper-catalyzed route for quinazolinones. High yield, mild conditions. Reliable pharmaceutical intermediate supplier for cost reduction.
Novel FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones offers high yield and scalability for pharmaceutical intermediates.
Patent CN112480015B details a one-pot method for quinazolinones, offering cost-effective routes for pharmaceutical intermediates and improved supply chain reliability.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. Enhances purity and reduces toxic gas usage for API manufacturing.
Patent CN113045503B reveals a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable production.
Patent CN111675662B details a novel FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel FeCl3-catalyzed route for 2-CF3 quinazolinones. High yield, scalable process for API intermediates. Cost-effective manufacturing solution.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable pharmaceutical intermediate supply chains.
Novel Pd-catalyzed carbonylation method for 2-trifluoromethyl quinazolinones. High yield, scalable route for API intermediates like Rutaecarpine.
Novel FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones offers high yield and scalability for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for quinazolinones using solid CO source. Safe, high-yield, scalable process for API intermediates and fine chemicals.
Novel Pd-catalyzed carbonylation method for quinazolinones offers high yield and scalability for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation route for 2-CF3 quinazolinones using solid CO sources. Enhances purity and safety for API manufacturing supply chains.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable pharmaceutical intermediate supply chains.
Patent CN113045503A details a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering high yields and simplified purification for API manufacturing.
Patent CN112480015B reveals a novel one-pot method for synthesizing 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN112480015B reveals a novel Pd-catalyzed one-pot method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN111675662A reveals a novel iron-catalyzed route for high-purity quinazolinone intermediates. Discover cost-effective manufacturing and scalable supply solutions.